Keynote Sessions

The following topics will be covered in this session:

• Strategic Overview: Understand the major drivers that are going to effect pharma's business model over the next 10 years
• Understand what the pharma New Commercial Model needs to look like to counteract current and future challenges and ensure profitability and shareholder value
• Hear how other industry's have changed their business models and what impact this has had on their profits
• New Customers, new influencers and tighter regulations – how do you change your sales and marketing activities to engage customers and impact sales results?
• How to improve image, reputation and value through your sales and marketing activities and how this will impact your sales
• The Empowered Patient and what this means for your business
• Emerging Markets – Understand the opportunities and how to structure your organization to maximize their potential

Confirmed speakers for this session:

Reinhard Angelmar, The Salmon and Rameau Fellow in Healthcare Management and Professor of Marketing INSEAD Patrick Cheron, Head of CRM Center of Excellence Region Europe & EGM Novartis Leandro Herrero, CEO The Chalfont Project Roland Powell Former European Director of Marketing & Sales Capabilities Eli Lilly & Company Michael Thomas, Principle, A T Kearney

Graham Stevenson Head of European SFE Celgene Penny Stobbs Senior Director, Business Excellence Wyeth Huw Tippett, Global Head of Sales Novartis John Stephens, Team Leader, Sales Force Support, Merck